Telitacicept Effective in Systemic Lupus Erythematosus The NEJM has published a report from van Vollenhoven et al… Read More
Biomol Biomed. 2025 Oct 20. doi: 10.17305/bb.2025.13043. Online ahead of print. ABSTRACT Assessment of insulin resistance is… Read More
SAIL-RA: Finding ILD in Early RA Cohort study of early rheumatoid arthritis (RA) patients finds that interstitial… Read More
FDA Approves Obinutuzumab for Active Lupus Nephritis jjcush@gmail.com Mon, 10/20/2025 – 18:17 Read More
FDA has approved Genentech’s CD20-targeting antibody obinutuzumab (Gazyva) for the treatment of adult patients with lu https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg… Read More
(MedPage Today) — Chimeric antigen receptor (CAR) T-cell therapy for blood cancers appeared less toxic, and patients’… Read More
Poster to be presented at American College of Rheumatology Convergence 2025 –BRISBANE, Calif., Oct. 20, 2025 (GLOBE… Read More
Retrospective study of 423 seropositiv RA pts (SPRA) finds 21% with baseline ILD; over 10 yrs 31%… Read More
Department of Rheumatology, Shaoxing Shangyu District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang Province, 312300, People’s Republic … Read More
For more information: Shivani Garg, MD, PhD, can be reached at sgarg@medicine.wisc.edu. Published by: healio rheumatology logo.… Read More